The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Aligning Science Across Parkinson's, 2020Co-Pathologies Drive Neuroinflammation and Progression in PD
Study Rationale:
While Parkinson’s disease (PD) is considered a synucleinopathy, the clinical progression of PD is driven by additional pathological proteins such as tau and beta-amyloid. Our... -
Therapeutic Pipeline Program, 2020Using Vestibular Stimulation to Improve Neurovascular Status in Parkinson’s Disease
Study Rationale:
Caloric vestibular stimulation activates the vestibular system, a sensory network with pathways spreading throughout the brain. The vestibular system is responsible for providing... -
Research Grant, 2020UCLA-California PD Registry-EHR (UCE-PD) Demonstration Project
Study Rationale:
We want to improve the quality of data being collected by the California Parkinson’s Disease Registry (CPDR). The CPDR now requires all clinicians in the state of California to report... -
Therapeutic Pipeline Program, 2020Dual-task Augmented Reality Treatment (DART) Protocol for Parkinson’s Disease
Study Rationale:
Approximately 80 percent of people with Parkinson’s disease fall due to problems with posture, walking and balance, known as postural and gait dysfunction (PIGD) one or more times a... -
Improved Biomarkers and Clinical Outcome Measures, 2020Developing Assays to Quantify Cys106 of DJ-1 in Distinct Oxidized States as a Potential Diagnostic Tool for Parkinson’s Disease
Study Rationale:
Currently, there are no tools to predict whether someone is at risk of developing Parkinson’s disease or to diagnose the early stages of the disease before motor symptoms can be... -
Research Grant, 2020Evaluation of ANAVEX2-73 (blarcamesine) in Participants with Parkinson’s Disease
Study Rationale:
We are testing ANAVEX2-73 (also known as blarcamesine), which previous research has shown helps improve behaviors as well as normalizes biochemical changes in a Parkinson’s...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.